[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354085-105":59,"doc-detail-354085-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cancer-ido1-mediated-tryptophan-kynurenine-metabolic-reprogramming-to-drive-skeletal-muscle-atrophy-and-cachexia-acceleration","Cancer IDO1-Mediated Tryptophan - Kynurenine Metabolic Reprogramming to Drive Skeletal Muscle Atrophy and Cachexia Acceleration","","Cancer cachexia is a debilitating syndrome marked by progressive skeletal muscle wasting that worsens quality of life and survival. Indoleamine 2,3-dioxygenase 1 (IDO1), an enzyme regulating tryptophan metabolism, is frequently elevated in cancers, but its mechanism in lung cancer–associated cachexia remains unclear. This study tests whether IDO1 drives cachexia via tryptophan–kynurenine metabolic reprogramming and evaluates whether pharmacologic inhibition can counter these effects.",{"@graph":69,"@context":122},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-ido1-mediated-tryptophan-kynurenine-metabolic-reprogramming-to-drive-skeletal-muscle-atrophy-and-cachexia-acceleration/354085/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-ido1-mediated-tryptophan-kynurenine-metabolic-reprogramming-to-drive-skeletal-muscle-atrophy-and-cachexia-acceleration/354085.png","ImageObject",300,407,{"name":92,"@type":93},"Sarah ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",25,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What question does the study address about IDO1 in cancer cachexia?","Question",{"text":113,"@type":114},"The study examines whether IDO1 mechanistically drives lung cancer–associated cachexia and whether blocking IDO1 can provide therapeutic benefit.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was IDO1 manipulated in the in vivo experiments?",{"text":118,"@type":114},"N/A",{"name":120,"@type":111,"acceptedAnswer":121},"What key metabolic changes were observed with Ido1 overexpression?",{"text":118,"@type":114},"https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354085,1790194254,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":14,"preview_urls":145},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Journal of Cachexia, Sarcopenia and Muscle  \n ORIGINAL ARTICLE  OPEN ACCESS   \nCancer IDO1-Mediated Tryptophan–Kynurenine Metabolic Reprogramming to Drive Skeletal Muscle Atrophy and Cachexia Acceleration  \nLeng Han1 | Lingjie Jing1 | Xinting Zhu1 | Ciqin Li1,2 | Lu Bai1,3 | Yang Fang1,3 | Yuxuan Zhou1,4 | Dingyuan Bai1,4 | Jin Lu1 | Yonglong Han1,4 | Cheng Guo1,2 | Shumin Zhou5 | Quanjun Yang1,3,4  \n1Department of Pharmacy, Shanghai Sixth People's Hospital Affiliated Shanghai Jiao Tong University School of Medicine, Shanghai, China | 2Shanghai University of Traditional Chinese Medicine, Shanghai, China | 3School of Biological and Biomedical Engineering, Donghua University, Shanghai, China | 4College of Food Science, Shanghai Ocean University, Shanghai, China | 5Institute of Microsurgery on Extremities, Shanghai Sixth People's Hospital Affiliated Shanghai Jiao Tong University School of Medicine, Shanghai, China  \nCorrespondence: Shumin Zhou ([zhoushumin_zw@126.com](zhoushumin_zw@126.com)) | Quanjun Yang ([myotime@sjtu.edu.cn](myotime@sjtu.edu.cn))  \nReceived: 7 December 2025 | Revised: 12 March 2026 | Accepted: 1 April 2026  \nKeywords: cancer cachexia | indoleamine 2,3-dioxygenase 1 | kynurenine | metabolic reprogramming | muscle atrophy | tryptophan  \nABSTRACT  \nBackground: Cancer cachexia is a debilitating syndrome characterized by severe skeletal muscle wasting, which significantly impairs patient quality of life and survival. Indoleamine 2,3-dioxygenase 1 (IDO1), a key enzyme in tryptophan (Trp) metabolism, is often upregulated in cancers, but its specific role in driving lung cancer–associated cachexia remains inadequately defined. This study investigated the mechanistic role of Ido1 in cancer cachexia and evaluated the therapeutic potential of its inhibition.  \nMethods: We established Lewis lung carcinoma (LLC) models in C57BL/6 mice using wild-type, Ido1-overexpressing (Ido1-OE) and Ido1-knockout (Ido1-KO) cells. Muscle mass, tumour growth and metabolic changes were assessed in vivo. Transcriptomicand targeted metabolomic analyses were performed on muscle and serum samples. In vitro, we examined the effects of tumourconditioned media, the Trp metabolite kynurenine (Kyn) and Trp supplementation on C2C12 myotube atrophy. In vivo experiments verified the efficacy of the Ido1 inhibitor palmatine hydrochloride (PAL). Molecular pathways were analysed via western blot and qPCR.  \nResults: Compared to LLC mouse models, Ido1-OE significantly exacerbated tumour growth and cachexia, leading to a significant decrease in lean body weight, gastrocnemius and tibialis anterior muscle weights (p \u003C 0.01, p \u003C 0.0001, p \u003C 0.001) . Gastrocnemius muscle fibre cross-sectional area significantly decreased in the Ido1-OE group (p \u003C 0.0001) . Transcriptomic analysis revealed that Ido1-OE activated pro-inflammatory and protein degradation pathways (upregulating MuRF1/Atrogin1, p \u003C 0.05) while suppressing anabolic signalling pathways (oestrogen pathways, p\u003C 0.01) . Metabolomics analysis revealed unique metabolic signatures in Ido1-OE mice: Trp depletion and Kyn accumulation. In vitro experiments demonstrated that Ido1-OE enhanced LLC cell proliferation and migration capabilities (p \u003C 0.0001, p\u003C 0.0001). Tumour-conditioned medium (TCM) derived from Ido1-OE tumours significantly induced C2C12 myotube atrophy (p \u003C 0.01). Similarly, direct treatment with Kyn led to dosedependent muscle fibre shrinkage, with significant atrophy observed at 30 μM (p \u003C 0.01) and 100 μM (p \u003C 0.0001) . Notably, themyotube atrophy induced by Kyn was significantly reversed by the addition of supplemental Trp (p \u003C 0.0001) . Compared with the Ido1-OE group, PAL treatment reduced gastrocnemius and tibialis anterior atrophy (p \u003C 0.01; p \u003C 0.05) . Mechanistically, PAL  \n\n| Leng Han, Lingjie Jing and Xinting Zhu contribute equally to this work. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution an","cbCaivXWMY0UOuly","https://ap.wps.com/l/cbCaivXWMY0UOuly","pdf",31444864,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Clinical impact of cancer cachexia","[{\"question\":\"What question does the study address about IDO1 in cancer cachexia?\",\"answer\":\"The study examines whether IDO1 mechanistically drives lung cancer–associated cachexia and whether blocking IDO1 can provide therapeutic benefit.\"},{\"question\":\"How was IDO1 manipulated in the in vivo experiments?\",\"answer\":\"N/A\"},{\"question\":\"What key metabolic changes were observed with Ido1 overexpression?\",\"answer\":\"N/A\"}]","Cancer IDO1-Mediated Tryptophan - Kynurenine Metabolic Reprogramming to Drive Skeletal Muscle Atrophy and Cachexia Acceleration | PDF",1790108835,48,[146,150],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/ae4326aa2a87538a1696930d7840cc7e.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/e151cc4fe86674fcb832a208af1f9052.webp",982,1290]